COVID-19 Therapeutics I: Drug combination for therapeutic induction of T cells against COVID-19 (IndTCOVID-19) - Conducting clinical study and immune monitoring
- Funded by Federal Ministry of Research, Technology and Space (BMFTR)
- Total publications:0 publications
Grant number: 03LW0005
Grant search
Key facts
Disease
COVID-19Start & end year
20212023Known Financial Commitments (USD)
$1,237,004.44Funder
Federal Ministry of Research, Technology and Space (BMFTR)Research Location
GermanyLead Research Institution
Eberhard Karls Universität TübingenResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnosticsResearch Subcategory
ImmunitySpecial Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
UnspecifiedBroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable
Abstract
N/A